|
|
||||||||
Ross Products Division of Abbott, Columbus, Ohio (A.M.F., T.D.S., Y.S.C.)
International Diabetes Center, Park Nicollet Institute, (D.M.K.)
Radiant Research Inc. (C.J.B.) Minneapolis, Minnesota
Address reprint requests to: Ann Marie Flammang PhD, RD, Ross Products Division of Abbott, 3300 Stelzer Rd, Columbus, OH 43219-3034. E-mail: ann.flammang{at}abbott.com
Objective: To compare the effect of an experimental viscous fiber (VF) crispy bar on the postprandial glucose, insulin, and C-peptide response in adult subjects with type 2 diabetes to two commercially available control crispy bars.
Design: The study was a randomized, double-blinded, three period, crossover study.
Setting: The study was conducted at two sites: Park Nicollet Institute, International Diabetes Center, Minneapolis, MN, and Radiant Research, Inc., Minneapolis, MN.
Subjects: A total of 60 adults with type 2 diabetes taking oral antihyperglycemic medication participated in the study.
Intervention: After an overnight fast, subjects consumed a test meal containing an equicaloric amount (300 kcal) of an experimental VF crispy bar or one of two commercially available crispy bars at each of three test visits, followed by a four hour meal tolerance test. Subjects also completed gastrointestinal (GI) response records for the 24 hours following each test visit.
Results: The VF crispy bars produced significantly lower glucose (p < 0.0001), insulin (p < 0.0001), and C-peptide (p < 0.0001) responses (as measured by positive area under the curve) in subjects with type 2 diabetes, as compared with the two commercially available bars. Intensity (p < 0.05) and frequency (p < 0.05) of flatulence were significantly higher with the VF bar as compared with the 2 commercial bars. While the VF bar produced significant subjective GI tolerance scoring values, the mean value was below 3 on a scale of 0 (no effect) to 10 (most severe effect) for all tested materials.
Conclusions: The incorporation of VF into a crispy bar provided a means to improve blood glucose levels by reducing postprandial glucose, insulin, and C-peptide responses in subjects with type 2 diabetes. Though associated with some GI symptoms, VF may have application in improving the postprandial glycemic response in people with diabetes attempting intensive glucose control.
Key words: dietary fiber, glucose, insulin, C-peptide, type 2 diabetes
This article has been cited by other articles:
![]() |
D. A. Timm and J. L. Slavin Dietary Fiber and the Relationship to Chronic Diseases American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 233 - 240. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |